Highway driving in the elderly the morning after bedtime use of hypnotics: A comparison between temazepam 20 mg, zopiclone 7.5 mg, and placebo

Journal of Clinical Psychopharmacology

Volumn 29, Issue 5, 2009, Pages 432-438

  Leufkens, Tim R M ^a   Vermeeren, Annemiek ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Cognitive and psychomotor performance; Elderly; Highway driving performance; Hypnotics; Residual effects; Temazepam; Zopiclone

Indexed keywords

PLACEBO; TEMAZEPAM; ZOPICLONE;

ADULT; AGED; ARTICLE; BEDTIME DOSAGE; CAR DRIVING; CLINICAL TRIAL; COGNITION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; HUMAN EXPERIMENT; LABORATORY TEST; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE;

AGE FACTORS; AGED; AUTOMOBILE DRIVING; AZABICYCLO COMPOUNDS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDDLE AGED; PIPERAZINES; PSYCHOMOTOR PERFORMANCE; TEMAZEPAM; TIME FACTORS; WAKEFULNESS;

EID: 70349655243     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3181b57b43     Document Type: Article

References (36)

1. Vermeeren A. Residual effects of hypnotics: epidemiology and clinical implications. CNS Drugs. 2004;18:297-328.
2. Busto UE, Sproule BA, Knight K, et al. Use of prescription and nonprescription hypnotics in a Canadian elderly population. Can J Clin Pharmacol. 2001;8:213-221.
3. Kassam A, Carter B, Patten SB. Sedative hypnotic use in Alberta. Can J Psychiatry. 2006;51:287-294.
4. Rosenberg RP. Sleep maintenance insomnia: strengths and weaknesses of current pharmacologic therapies. Ann Clin Psychiatry. 2006;18: 49-56.
5. O'Hanlon JF, Volkerts ER. Hypnotics and actual driving performance. Acta Psychiatr Scand. 1986;332:95-104.
6. Vermeeren A, Danjou PE, O'Hanlon JF. Residual effects of evening and middle-of-the-night administration of zaleplon 10 and 20 mg on memory and actual driving performance. Hum Psychopharmacol. 1998;13:S98YS107.
7. Vermeeren A, Riedel WJ, van Boxtel MP, et al. Differential residual effects of zaleplon and zopiclone on actual driving: a comparison with a low dose of alcohol. Sleep. 2002;25:224-231.
8. Leufkens TRM, Lund JS, Vermeeren A. Highway driving performance and cognitive functioning the morning after bedtime and middle-of-the-night use of gaboxadol, zopiclone and zolpidem. J Sleep Res. June 2009. [Epub ahead of print]. DOI:10.1111/ j.1365
9. Drake CL, Roehrs T, Roth T. Insomnia causes, consequences, and therapeutics: an overview. Depress Anxiety. 2003;18:163-176.
10. Glass J, Lanctot KL, Herrmann N, et al. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. Br Med J. 2005;331:1169-1175.
11. Woodward M. Hypnosedatives in the elderly. CNS Drugs. 1999; 11:263-279.
12. Hemmeter U, Muller M, Bischof R, et al. Effect of zopiclone and temazepam on sleep EEG parameters, psychomotor and memory functions in healthy elderly volunteers. Psychopharmacology. 2000;147:384-396.
13. O'Hanlon JF, Haak TW, Blaauw GJ, et al. Diazepam impairs lateral position control in highway driving. Science. 1982;217:79-81.
14. O'Hanlon JF. Driving performance under the influence of drugs: rationale for, and application of, a new test. Brit J Clin Pharmacol. 1984;18:121s-129s.
15. Ramaekers JG. Antidepressants and driver impairment: empirical evidence from a standard on-the-road test. J Clin Psychiatry. 2003;64:20-29.
16. Theunissen EL, Vermeeren A, Vuurman EFPM, et al. Drugs, driving and traffic safety in allergic rhinitis. In: Verster JC, Pandi-Perumal SR, Ramaekers JG, De Gier JJ, eds. Drugs, Driving and Traffic Safety. Basel: Birkhauser; 2009:371-382.
17. Vermeeren A, Leufkens TRM, Verster JC. Effects of anxiolytics on driving. In: Verster JC, Pandi-Perumal SR, Ramaekers JG, De Gier JJ, eds. Drugs, Driving and Traffic Safety. Basel: Birkhauser; 2009:289-306.
18. Volkerts ER, O'Hanlon JF. Residu effecten van voorgeschreven hypnotica op de actuele rijprestatie (Residual effects of prescribed hypnotics on actual driving performance; Dutch with English summary and legends). J Drug Res. 1988;13:111-114.
19. Vermeeren A, O'Hanlon JF, Declerck AC, et al. Acute effects of zolpidem and flunitrazepam on sleep, memory and driving performance, compared to those of partial sleep deprivation and placebo. Acta Ther. 1995;21:47-64.
20. Verster JC, Volkerts ER, Schreuder AH, et al. Residual effects of middle-of-the-night administration of zaleplon and zolpidem on driving ability, memory functions, and psychomotor performance. J Clin Psychopharmacol. 2002;22:576-583.
21. Ramaekers JG, Muntjewerff ND, Uiterwijk MMC, et al. A study of the pharmacodynamic interaction between befloxatone and ethanol on performance and mood in healthy volunteers. J Psychopharmacol. 1996;10:288-294.
22. Jex HR, McDonnell JD, Phatak AV. A Bcritical[ tracking task for manual control research. IEEE Trans Hum Fac El. 1966;7:138-145.
23. Moskowitz H. Proceedings: Psychological tests and drugs. Pharmakopsychiatr Neuropsychopharmakol. 1973;6:114-126.
24. Logan GD, Cowan WB, Davis KA. On the ability to inhibit simple and choice reaction time responses: a model and a method. J Exp Psychol Hum Percept Perform. 1984;10:276-291.
25. Rey A. L'examen clinique en psychologie. Paris: Presses Universitaires de France; 1964.
26. Kapteyn TS, Bles W, Njiokiktjien CJ, et al. Standardization in platform stabilometry being part of posturography. Agressol. 1983; 24:321-326.
27. Boyle J, Danjou P, Alexander R, et al. Tolerability, pharmacokinetics and night-time effects on postural sway and critical flicker fusion of gaboxadol and zolpidem in elderly subjects. Brit J Clin Pharmacol. 2008;67:180-190.
28. Bond A, Lader M. The use of analogue scales in rating subjective feelings. Brit J Med Psychol. 1974;47:211-218.
29. Hoddes E, Dement W, Zarcone V. The development and use of the Stanford Sleepiness Scale. Psychophysiology. 1972;9:150.
30. Mulder-Hajonides van der Meulen WREH. Measurement of subjective sleep quality. Proceedings of the International European Sleep Conference. Amsterdam: Elsevier; 1981.
31. Louwerens JW, Gloerich ABM, de Vries G, et al. The relationship between drivers' blood alcohol concentration (BAC) and actual driving performance during high speed travel. In: Noordzij PC, Roszbach R, eds. International Congress on Alcohol, Drugs and Traffic Safety, T86. Amsterdam: Exerpta Medica; 1987:183-186.
32. Riedel WJ, Quasten R, O'Hanlon JF. Effects of midazolam triazolam and temazepam on shiftworkers' day-sleep and subsequent driving performance. Psychopharmacology. 1988;96:156S.
33. Van Laar MW, Van Willigenburg AP, Volkerts ER. Acute and subchronic effects of nefazodone and imipramine on highway driving, cognitive functions, and daytime sleepiness in healthy adult and elderly subjects. J Clin Psychopharmacol. 1995;15:30-40.
34. International Council on Alcohol Drugs and Traffic Safety (ICADTS). Guidelines on experimental studies undertaken to determine a medicinal drug's effect on driving or skills related to driving. Cologne: Bundes Anstalt fuer Strassenwesen (BASt); 1999:1-13.
35. Bateson AN. Basic pharmacologic mechanisms involved in benzodiazepine tolerance and withdrawal. Curr Pharm Design. 2002;8:5-21.
36. Neutel I. Benzodiazepine-related traffic accidents in young and elderly drivers. Hum Psychopharmacol. 1998;13:S115-S123.